Practice Management News

COVAX, the multinational program launched in 2020 to deliver COVID-19 vaccines to low- and lower-middle income countries, will end on Dec. 31, 2023, as the vaccines shift to routine immunization programs.

Contamination of the health care environments near patients who are colonized with Candida auris often occurs within 4 hours, researchers found.

SARS-CoV-2 rebound risk is more likely related to the individual person, rather than reinfection or resistance to treatment such as Paxlovid, according to two studies.

As viral hepatitis continues to be a major health concern in the infectious disease field, recent research has highlighted the importance of testing and treatment.

Efforts to raise flagging childhood vaccination rates increased in 2023 as new shots hit the market.

Healio reporters filed more than 100 stories from infectious diseases meetings in 2023, most of them on the road in cities like Boston, Philadelphia, Orlando, Houston and Seattle.

Young children with respiratory syncytial virus were hospitalized at a higher rate in the years after the start of the COVID-19 pandemic than in the six seasons before it, according to a study in JAMA Pediatrics.

The front page of Healio | Infectious Disease News this year included stories about COVID-19, new vaccines, reversing decades of ID dogma, and more.

As the COVID-19 pandemic enters its 5th year, its effect on children continues to be widely studied. We compiled a list of stories about pediatric COVID-19 that we reported over the course of the past year.

To mark the end of 2023, we compiled a list of this year’s Pharmacology Consult columns, in which our contributing PharmDs dig deep into the newest research to report on emerging therapies and vaccines for infectious diseases.